Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Robert W. Hammel"'
Publikováno v:
American Journal of Health-System Pharmacy. 42:566-570
The economic feasibility of implementing a prime vendor purchasing system for pharmaceuticals was evaluated in a midwestern university hospital. Inventory costs, personnel costs, and check processing costs under the current purchasing system were com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a12d817a38915156c0896e428f416e1
https://doi.org/10.1093/ajhp/42.3.566
https://doi.org/10.1093/ajhp/42.3.566
Publikováno v:
Journal of Pharmaceutical Marketing & Management. 2:131-146
Pharmacists' opinions about pharmaceutical manufacturers are important to manufacturers in fortnulating marketing strategies and policies. For both research-intensive and principally generic manufacturers, we (1) identified and investigated their agg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4eb0a77bbb2b1c29ed45cec76efb36c
https://doi.org/10.3109/j058v02n01_10
https://doi.org/10.3109/j058v02n01_10
Autor:
Robert W. Hammel, Paul O. Williams
Publikováno v:
Journal of the American Pharmaceutical Association (1961). 4:331-337
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ec1fa4f7154e9376a8af37450a98a473
https://doi.org/10.1016/s0003-0465(15)31129-0
https://doi.org/10.1016/s0003-0465(15)31129-0
Autor:
Michael Dayenian, Robert W. Hammel
Publikováno v:
Journal of the American Pharmaceutical Association (1961). 1:626-631
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::091d7c6556f8ff5822751a24e5b6840d
https://doi.org/10.1016/s0003-0465(15)33720-4
https://doi.org/10.1016/s0003-0465(15)33720-4
Publikováno v:
Journal of the American Pharmaceutical Association (1961). 1:155-157
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a44bf235a067a1fb14d348e0eb2c1f0
https://doi.org/10.1016/s0003-0465(15)33479-0
https://doi.org/10.1016/s0003-0465(15)33479-0
Publikováno v:
Journal of pharmaceutical marketingmanagement. 3(2)
The effects of a Medicaid formulary restriction, adding propoxyphene napsylate to a Negative Drug List, were examined. The market shares of products in subgroups of the internal analgesic therapeutic category were compared for periods before and afte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fd25b3cec242cf7f3aac5dfc3c97948
https://pubmed.ncbi.nlm.nih.gov/10314666
https://pubmed.ncbi.nlm.nih.gov/10314666
Publikováno v:
Medical care. 27(1)
The effects of removing propoxyphene napsylate products from the Wisconsin Medicaid drug program formulary were examined. Internal analgesic expenditures and usage data for 3-month periods before and after the removal were compared (April through Jun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd7923a40c6d8c1e20f147077693040
https://pubmed.ncbi.nlm.nih.gov/2562996
https://pubmed.ncbi.nlm.nih.gov/2562996
Autor:
Robert W. Hammel, John A. Bachynsky
Publikováno v:
Journal of the American Pharmaceutical Association. 9(6)
Governmental units are fiscally responsible for their expenditures. To ensure their responsibility is fulfilled, there must be administrative control procedures and reviews of expenditures. Expenditures for drugs are no exception. In studying the var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b20da326856fd5d62d94f832f3a60e8
https://pubmed.ncbi.nlm.nih.gov/5783576
https://pubmed.ncbi.nlm.nih.gov/5783576
Autor:
Raymond J. Bennett, Robert W. Hammel
Publikováno v:
Journal of the American Pharmaceutical Association (1961). 5:206-207
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::998e17e649884e8aefeda1109afaf3d0
https://doi.org/10.1016/s0003-0465(15)33824-6
https://doi.org/10.1016/s0003-0465(15)33824-6
Autor:
Robert W. Hammel
Publikováno v:
JAMA: The Journal of the American Medical Association. 219:1740
Public assistance medical care expenditure data supplied to the US Department of Health, Education, and Welfare by nine Western and ten Southern state were analyzed. For comparison purposes, data from states without a drug formulary or with an open o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ecb14acb771bc38b5d023e09b83f788
https://doi.org/10.1001/jama.1972.03190390026007
https://doi.org/10.1001/jama.1972.03190390026007